APRN-Led Discharge Program Reduces Readmission Rates Following Treatment With Immune Checkpoint Inhibitors
Source: Onc Nursing News, December 2022
APRNs developed a discharge program which reduced readmission rates for patients receiving immunotherapy for advanced melanoma.
An advanced-practice RN (APRNs) led discharge education and follow-up program reduced the readmission rate for patients with melanoma who were treated with immune checkpoint inhibitor (ICI) therapy. The findings of the program were published in the Clinical Journal of Oncology Nursing.
In the pre-initiative setting (n = 32), 11 patients needed to be readmitted because of an ICI-related toxicity. However, post intervention (n = 13), no patients were readmitted because of an ICI-related toxicity.